BeStock  
Stocks › Biotechnology › LXRX

Lexicon Pharmaceuticals LXRX

US equityMarket cap rank #3424Biotechnology
$1.76 +$0.01 (+0.57%)
Pre-market · Oct 8, 9:00 am ET · After hours $1.76 0.00%
Open$1.73
Prev close$1.75
Day range$1.71 – $1.77
Volume1.10M
Market cap$783.12M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-11.0x
CheapRich

Near the bottom of its 5-year range · 12th percentile, 5-year average -5.3x

Price / book4.5x
CheapRich

Above its usual level · 69th percentile, 5-year average 3.7x

#4181 of 5317 stocks by PB (1 = cheapest)

Price / sales18.9x
CheapRich

Below its usual level · 29th percentile, 5-year average 1,089.4x

#4657 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-40x-22x-3x16xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$2.03
Price vs. fair value-13.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.49 – 3.65 69% (pricier than usual) #4181 of 5317 (1 = cheapest)
PE -11.00 -7.81 -5.28 12% (cheaper than usual) –
PS 18.88 47.17 1,089.40 29% (cheaper than usual) #4657 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$2.03
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on LXRX.

Leave a comment

Scroll to Top